Stock Events

Stock Events

Bioporto AS 

€0.1
15
+€0+0.6% Today

Statistics

Day High
0.1
Day Low
0.1
52W High
0.2
52W Low
0.1
Volume
-
Avg. Volume
-
Mkt Cap
45.83M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
Next
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-188.29%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
9.72MRevenue
-18.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2P4.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes with BioPorto in the diagnostics and medical devices sector, particularly in areas related to kidney health and diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers a range of products for the life science research and clinical diagnostics markets, overlapping with BioPorto's diagnostic solutions.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the diagnostics and research sector, directly competing with BioPorto in the development of diagnostic tests and products.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with BioPorto's offerings.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company competes in the medical technology sector, offering products for diagnostics, healthcare worker safety, and infection prevention that overlap with BioPorto's market.
Resmed
RMD
Mkt Cap36.04B
ResMed Inc. specializes in cloud-connectable medical devices for sleep apnea, COPD, and other chronic diseases, indirectly competing with BioPorto in the broader healthcare diagnostics market.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products for women's health, competing with BioPorto in the diagnostics segment.
QuidelOrtho
QDEL
Mkt Cap1.83B
Quidel Corporation specializes in diagnostic healthcare solutions, including rapid diagnostic testing, competing directly with BioPorto's diagnostic products.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that, while focused on cancer, compete in the broader diagnostics market against BioPorto's solutions.

About

BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. It sells its products through own sales team, distributors, and OEM partnerships. The company was founded in 2000 and is headquartered in Hellerup, Denmark.
Show more...
CEO
Mr. Niels Hoey Nielsen
Employees
48
Country
DK
ISIN
DK0011048619
WKN
000893191

Listings

OTC Link
US
THOXF
CO
DK
BIOPOR.CO
F
DE
2P4.F
LSE
GB
0JJM.LSE

0 Comments

Share your thoughts

FAQ

What is Bioporto AS stock price today?▼
The current price of 2P4.F is €0.1 EUR — it has increased by +0.6% in the past 24 hours. Watch Bioporto AS stock price performance more closely on the chart.
What is Bioporto AS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bioporto AS stocks are traded under the ticker 2P4.F.
Is Bioporto AS stock price growing?▼
2P4.F stock has fallen by -5.26% compared to the previous week, the month change is a -1.37% fall, over the last year Bioporto AS has showed a -40.91% decrease.
What is Bioporto AS market cap?▼
Today Bioporto AS has the market capitalization of 45.83M
When is the next Bioporto AS earnings date?▼
Bioporto AS is going to release the next earnings report on May 21, 2026.
What is Bioporto AS revenue for the last year?▼
Bioporto AS revenue for the last year amounts to 9.72M EUR.
What is Bioporto AS net income for the last year?▼
2P4.F net income for the last year is -18.3M EUR.
How many employees does Bioporto AS have?▼
As of April 01, 2026, the company has 48 employees.
In which sector is Bioporto AS located?▼
Bioporto AS operates in the Health Care sector.
When did Bioporto AS complete a stock split?▼
Bioporto AS has not had any recent stock splits.
Where is Bioporto AS headquartered?▼
Bioporto AS is headquartered in Hellerup, DK.